Why the study?
Does the use of automatic implantable cardio-defibrillators improve survival in children with cardiomyopathy and refractory ventricular dysrhythmias?
Does the use of automatic implantable cardio-defibrillators improve survival in children with cardiomyopathy and refractory ventricular dysrhythmias?
Answers are grounded in this paper and cite their sources.
This early case series demonstrates the feasibility of using automatic implantable cardio-defibrillators in young children with cardiomyopathy and refractory ventricular dysrhythmias.
Children and adults with cardiomyopathy and ventricular dysrhythmias have a uniformly poor prognosis, despite medical therapy. The use of automatic implantable cardio-defibrillators in adult patients with medically resistant ventricular dysrhythmias has resulted in a positive impact on survival. Because of its size and former lack of programmability, the device has been used rarely in children. Four patients with cardiomyopathy, in whom refractory ventricular dysrhythmias were managed with automatic implantable cardio-defibrillators, are presented. Two of these children are the youngest and smallest known in whom the device has been used; one of them received the first programmable model. The use of the automatic implantable cardio-defibrillator may enhance survival in selected young patients.
No takes yet. Share an insight, caveat, or question.
Kaminer et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: